Mathew Garnett
Computational Theory and Mathematics · 2004–2019
A researcher in the Science corpus: 10 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Computational Theory and Mathematics — 17 citations into it
- Statistics and Probability — 5 citations into it
Whom Mathew Garnett trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Mathew Garnett overall
- Paul Geeleher
- R. Roskoski
- Nancy J. Cox
- M. Dawson
- Michael P. Menden
- Ping Wee
- R. Shaw
- H. Shigematsu
- David Ramírez
- Dusica Vidovic
Papers from Mathew Garnett's perspective
Ordered by how strongly the researchers Mathew Garnett trusts endorse each paper. Same corpus, a different order for every researcher.
- Addendum: Regularization and variable selection via the elastic net
- Systematic variation in gene expression patterns in human cancer cell lines (Nature Genetics)
- Random Forests
- The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity (Nature)
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer (New England Journal of Medicine)
- Systematic identification of genomic markers of drug sensitivity in cancer cells (Nature)
- Discovery and saturation analysis of cancer genes across 21 tumor types (Nature)
- Pan-cancer patterns of somatic copy-number alteration (Nature Genetics)
- Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer (Nature Chemical Biology)
Their papers
- Systematic identification of genomic markers of drug sensitivity in cancer cells (2012) — 2,417 citations
- Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen (2019) — 299 citations
- Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties (2012) — 475 citations
- Guilty as charged: B-RAF is a human oncogene. (2004) — 864 citations
- A Landscape of Pharmacogenomic Interactions in Cancer (2016) — 1,831 citations
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells (2012) — 3,577 citations
- Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens (2019) — 1,126 citations
- Perturbation-response genes reveal signaling footprints in cancer gene expression (2016) — 858 citations
- Human Primary Liver Cancer -derived Organoid Cultures for disease modelling and drug screening (2017) — 1,256 citations
- Prospective derivation of a Living Organoid Biobank of colorectal cancer patients (2015) — 2,171 citations